Anchor the answer in the formal classification criteria for APS, which require a clinical event (clot or recurrent pregnancy loss) plus a laboratory antibody that stays positive on repeat testing 12 weeks later.
Only three antibody assays count toward the laboratory limb: lupus anticoagulant, anticardiolipin, and anti-beta 2 glycoprotein I. From the choices listed, the one that matches is the anti-beta 2 glycoprotein I antibody, an antibody directed against the plasma cofactor that mediates much of the prothrombotic effect in APS.
The trap option is beta 2 microglobulin antibody, which sounds similar but is a different molecule entirely (beta 2 microglobulin is a tumour and renal marker, not an antiphospholipid target). Antinuclear antibody is the lupus screen, and anti-centromere antibody flags limited scleroderma/CREST; neither is part of the APS criteria.
So the diagnostic test from this set is the anti-beta 2 glycoprotein I antibody.
\[\boxed{\text{Anti beta 2 glycoprotein I antibody}}\]